Navigation Links
Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A
Date:7/22/2008

ext weeks the appointment of corporate advisers to assist with the identification of and initial discussion with potential acquisitions in Australia and the United States.

Cash Position as at 30 June 2008: $76.7m, excluding creditors and accruals of $6.2m (unaudited).

On behalf of the Board of Directors and Management,

Dr Mal Eutick

Chairman

About Progen: Progen Pharmaceuticals is a globally focused biotechnology company committed to the discovery, development and commercialization of small molecule pharmaceuticals primarily for the treatment of cancer. Progen has built a focus and strength in anti-cancer drug discovery and development. Progen targets the multiple mechanisms of cancer across its three technology platforms, angiogenesis, epigenetics and cell proliferation. Progen has operations in Australia and the US.

Contact Point:

Dr Mal Eutick

Chairman

0416 177 772

Justus Homburg

CEO, Managing Director

T: +61 7 3842 3333

Linton Burns

Company Secretary

T: +61 7 3842 3333

Contact details:

Progen Pharmaceuticals Limited

ABN 82 010 975 612

PO Box 2403 Toowong Qld 4066

T: +61 7 3842 3333

F: +61 7 3720 9624

W: http://www.progen-pharma.com


'/>"/>
SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Presentation of Data on Progens Cancer Epigenetic Targets Platform
2. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
3. Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047
4. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
5. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
6. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
7. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
8. Progen Announces PI-88 Phase 2 Lung Cancer Results
9. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
10. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
11. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 Pomerantz ... investigating claims on behalf of investors of Intuitive Surgical, ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive Surgical common ... (the "Class Period"). Such investors are advised to contact ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ...
(Date:5/22/2013)... Minn. , May 22, 2013 /PRNewswire/ ... the successful completion of its global Phase ... an internally developed program for the management ... proprietary formulation technology.  USL255 is specifically engineered ... fluctuations in topiramate blood levels observed with ...
(Date:5/22/2013)... Mass. and TORONTO , ... ) (OTCBB: GNBT) today announced three presentations demonstrating the ... by its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ... meeting of the American Society of Clinical Oncology (ASCO) ... from May 31 through June 4, 2013. ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4
... Apollo Endosurgery, Inc. announced that their newly-launched OverStitch™ ... several, first-in-human cases. ... that mimics the way physicians deploy sutures by hand. ... delivering surgical standard of care through the flexible endoscope. ...
... 28 Danaher Corporation (NYSE: DHR ) announced ... Comas will be presenting at the Goldman Sachs Global Industrials ... at 10:15 a.m. EDT. The company also announced that President ... presenting at the Robert W. Baird Industrial Conference in Chicago, ...
Cached Medicine Technology:Apollo Endosurgery Completes First-in-Human Cases With New OverStitch™ Endoscopic Suturing System 2
(Date:5/23/2013)... Nashville, TN (PRWEB) May 23, 2013 ... to enhance nurse understanding of the professional role and ... , Roland Joy, vice president of patient care services ... explains, "TAMC nurses are excellent clinicians, and we want ... profession, teach them that to lead they must follow, ...
(Date:5/23/2013)... PhD Box has introduced a ... the research process by offering assistance for Thesis Proposals. The ... of services that the company provides for research consultation in ... dedicated proposal writing service is that this is the stage ... research process find it difficult to draft a proposal as ...
(Date:5/23/2013)... Following the recent outbreak of fake ... the security team at idcloak Technologies has identified a ... or any web-born malware. Gill-Chris Welles of the ... better privacy and security than traditional antivirus ... the best AV software cannot be depended on: it ...
(Date:5/23/2013)... When Teachers Notebook reached out to its teacher ... the Moore, OK tornado victims, they hoped to attract ... be sold for around $10.00 with all proceeds benefiting ... were overwhelmed by the response from these dedicated educators ... the first 12 hours of the campaign. , Later ...
(Date:5/23/2013)... GBI Research’s analysis indicates that the global critical ... number of players accounting for a major proportion of the ... rate between 2006 and 2012, possibly due to the lack ... especially in the US. , GBI Research estimates that ... in 2012, having grown in size at a CAGR of ...
Breaking Medicine News(10 mins):Health News:OnSomble, Inc. Partners with The Aroostook Medical Center to Enhance Nurse Understanding of the Professional Role 2Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2Health News:Effective virus protection without anti-virus software, identifies idcloak 2Health News:Teachers Rally to Raise Funds for Moore Tornado Victims 2Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2
... no open choices. But does this also mean no end-of life ... The department of health recently spoke of 60% compliance of ... elderly. ,To research into this lofty claim, a survey ... lives, often die a lonely death. Nearly 50% of the 800 ...
... this bit of news sent you into an instant cardio-vascular ... soil and the rest, who probably don’t engage// in heart ... ill health. This region portraying a high incidence of cardiovascular ... ,A major health initiative is taking shape under the ...
... can be treated in a short time if diagnosed properly. ... Body CT, the ultrasound technology could be used to accurately ... ,One condition that many runners seek treatment for ... the heel, caused by the back of the shoe consistently ...
... weighed less than 1lb 6oz. He was so weak that he ... ensured that he lived and grew stronger. //Even his mother Donna ... had to be given blood transfusions to recover. ,Now ... those who helped them, they are launching a campaign to fill ...
... has said that suicide rates in Sri Lanka has increased in ... yellow oleander plants even for the most trivial reasons. ... all over the island. It has yellow trumpet-like flowers and a ... seed and one of these seeds is enough to kill you, ...
... million Australians have diabetes. New South Wales (NSW) has recorded ... over the past 10 years. Experts have asked the health ... diabetes. Sooner if it continues it is expected that about ... reason for this increase is that of the diet and ...
Cached Medicine News:Health News:Hush…..A Deadly Killer on the Prowl in Rural Andhra Pradesh 2Health News:Proper Diagnosis Could Augment Speedy Recovery Of Haglund’s Syndrom 2Health News:Its High Time the Australian Government Takes Steps against Diabetes 2
Very fine, blunt tip....
... Designed to meet the ... of cardiology practices. The ... attenuation correction accessory features ... array that increases the ...
Stainless steel lancet blade in stainless steel....
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
Medicine Products: